AlphaQuest’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$264K Buy
12,956
+844
+7% +$17.2K 0.03% 965
2025
Q1
$220K Buy
12,112
+7,825
+183% +$142K 0.02% 936
2024
Q4
$108K Buy
4,287
+2,705
+171% +$68.4K 0.01% 1069
2024
Q3
$53.8K Sell
1,582
-5,801
-79% -$197K ﹤0.01% 1398
2024
Q2
$273K Buy
7,383
+6,879
+1,365% +$255K 0.04% 663
2024
Q1
$21.2K Buy
+504
New +$21.2K ﹤0.01% 1029